Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 5:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3145–3168 of 9,470 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intervention Condition Clear all

Conditions: Small Cell Lung Cancer (SCLC)
Interventions: PF-08634404, Atezolizumab, Chemotherapy; Drug · Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2034
U.S. locations: 54
States / cities: Fayetteville, Arkansas • Rogers, Arkansas • Springdale, Arkansas + 41 more

Conditions: Alcohol Abuse, Substance Use
Interventions: Bright Horizons, Case Management; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 10 Years to 24 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Whiteriver, Arizona

Conditions: Sepsis, Septic Shock, Sepsis With Acute Organ Dysfunction
Interventions: Not listed
Lead sponsor: Axis Shield Diagnostics Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 571 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 5
States / cities: Philadelphia, Pennsylvania • York, Pennsylvania • Nashville, Tennessee + 1 more

Conditions: Coronavirus, Covid19
Interventions: N-acetyl glucosamine (NAG), Control; Dietary Supplement · Other
Lead sponsor: Quantinosis.ai LLC; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Harlingen, Texas

Conditions: Frailty
Interventions: Physical Therapy; Other
Lead sponsor: University of Chicago; Other
Eligibility: 60 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Abdominal Pain/ Discomfort, Irritable Bowel Syndrome
Interventions: Music intervention; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Acute Myocardial Infarction
Interventions: ClearWay™ Rx catheter; Device
Lead sponsor: Cardiovascular Institute of the South Clinical Research Corporation; Other
Eligibility: 18 Years to 80 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Lafayette, Louisiana

Conditions: Peripheral Artery Disease
Interventions: Rivaroxaban (Xarelto, BAY59-7939), Rivaroxaban-Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 50 Years and older
Enrollment: 6,564 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 105
States / cities: Alexander City, Alabama • Birmingham, Alabama • Fort Payne, Alabama + 91 more

Conditions: Breast Cancer Female, Inflammation, Postpartum Weight Retention, Diet, Healthy, Risk Reduction
Interventions: Dietary Counseling; Behavioral
Lead sponsor: University of Massachusetts, Amherst; Other
Eligibility: 18 Years and older · Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Amherst, Massachusetts

Conditions: Surgical Site Infection
Interventions: povidone-iodine topical ointment; Drug
Lead sponsor: Loreen Herwaldt; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 6
States / cities: Atlanta, Georgia • Indianapolis, Indiana • Iowa City, Iowa + 3 more

Conditions: Internet-based Intervention, Web-based Intervention, Online Intervention, Erectile Dysfunction, Telemedicine
Interventions: An automated patient-reported outcome data collection and adverse event surveillance tool; Other
Lead sponsor: Ro; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Bipolar Disorder
Interventions: Replicating Effective Programs Framework for the Bipolar Care Model, Bipolar Care Model Package Only; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 3
States / cities: Denver, Colorado • Ann Arbor, Michigan

Conditions: Celiac Disease, Infant Nutrition
Interventions: Gluten, Gluten free diet; Dietary Supplement
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Up to 6 Months
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Bipolar Disorder, Bipolar I Disorder, Bipolar II Disorder, Bipolar Type I Disorder, Bipolar Disorder Mild, Bipolar Disorder Moderate, Bipolar Disorder Severe
Interventions: No intervention; Other
Lead sponsor: ProgenaBiome; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Ventura, California

Conditions: Epilepsy
Interventions: Project Dream Team; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 12 Years to 26 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 1 Diabetes Mellitus
Interventions: Promoting Resilience in Stress Management (PRISM); Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 2
States / cities: Houston, Texas • Seattle, Washington

Conditions: Diabetes Mellitus Type 2
Interventions: Harnessing Online Peer Education; Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Irvine, California

Conditions: Patellofemoral Pain, Patellofemoral Pain Syndrome
Interventions: Emovi Knee Kinesiography; Device
Lead sponsor: Womack Army Medical Center; Federal
Eligibility: 18 Years to 50 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Honolulu, Hawaii • Fort Liberty, North Carolina

Conditions: Chronic Kidney Disease + Hyperkalaemia +/- Heart Failure
Interventions: Calcium Polystyrene Sulphonate 15g/60 mL water, Lokelma® 5 g/45mL water, Lokelma® 10 g/45 mL water, Veltassa® 8,4 g/80mL water, Sodium Polystyrene Sulphonate 15g/60 mL water; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Temple Terrace, Florida • West Palm Beach, Florida

Conditions: Polycystic Ovary Syndrome (PCOS)
Interventions: Cognitive Behavioral Therapy, Nutrition Counseling; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hepatitis
Interventions: Emapalumab; Drug
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: 1 Year to 30 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cerebral Palsy, Hemiplegic Cerebral Palsy
Interventions: Therapy Together, Usual Care; Behavioral
Lead sponsor: Texas Scottish Rite Hospital for Children; Other
Eligibility: 3 Months to 71 Months
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Frisco, Texas

Conditions: High Blood Pressure
Interventions: MyBP, Personal BP monitor; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 55 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Angioplasty
Interventions: eptifibatide; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Adaptation and Evaluation of Bright Horizons

Assessment of Heparin Binding Protein for the Prediction of Severe Sepsis

N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)

Intervention for Pre-Frailty and Frailty in Thoracic Surgery Patients

The Mechanism Underlying the Analgesic Effect of the Music of IBS Pain

ClearWay Rx Readmission Registry

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer Risk

PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)

Evaluating Treatment Continuation in Telehealth Patients Receiving an Automated Patient-Reported Outcome Tool

Adapting the Bipolar Care Model for Chronic Care Management in Community-based Health Care Sites

Infant Nutrition and Risk of Celiac Disease

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Bipolar Disorder

A Novel Social Emotional Learning Curriculum for Youth With Epilepsy

PRISM for Adolescents With Type 1 Diabetes

HOPE Intervention for Fitness

Emovi 3D Knee Assessment Device Intervention for Operational Readiness

Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and Hyperkalaemia

Mood and Nutrition Interventions in Polycystic Ovary Syndrome

Severe Hepatitis Intervention With Emapalumab for Liver Disease

Implementation of Therapy Together

High BP and Home Monitoring Experience (HoME) Study

Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty